Trials / Completed
CompletedNCT02123030
A Micro/Nano Device for Exhaled Breath Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 728 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Use of a microfabricated silicon device to concentrate ultra trace volatile organic compounds (VOCs) in human exhaled breath for quantitative analysis of VOCs.
Detailed description
Will use Fourier Transform Mass Spectrometry (FT-MS) and Gas Chromatography-Mass Spectrometry (GC-MS) to analyze concentrated VOCs. The purpose of this study is to search for disease-related markers in the breath in subjects with known or suspected lung or other cancer, or pulmonary disease.
Conditions
Timeline
- Start date
- 2012-11-07
- Primary completion
- 2018-11-28
- Completion
- 2018-11-28
- First posted
- 2014-04-25
- Last updated
- 2021-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02123030. Inclusion in this directory is not an endorsement.